NUP214 and cardiac hypertrophy: Having demonstrated the siRNA activity of the Cond-siRNA in NRVMs in the presence of PE-induced upregulation of Nppa, we next sought to characterize the effects of the Cond-siRNAs on CaN and its downstream signaling and the expression of other pathological cardiac hypertrophy markers under baseline (PBS) or PE treatment.30